| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | APO | Common Stock | Sale | -$1.17M | -10.7K | -0.22% | $109.94 | 4.86M | Mar 1, 2024 | Direct | F1, F2 |
| transaction | APO | Common Stock | Sale | -$14.8M | -134K | -2.76% | $110.39 | 4.72M | Mar 1, 2024 | Direct | F2, F3 |
| transaction | APO | Common Stock | Sale | -$2.93M | -26.4K | -0.56% | $111.30 | 4.7M | Mar 1, 2024 | Direct | F2, F4 |
| transaction | APO | Common Stock | Sale | -$402K | -3.57K | -0.08% | $112.35 | 4.69M | Mar 1, 2024 | Direct | F2, F5 |
| transaction | APO | Common Stock | Sale | -$83.3K | -736 | -0.02% | $113.13 | 4.69M | Mar 1, 2024 | Direct | F2, F6 |
| transaction | APO | Common Stock | Sale | -$289K | -2.63K | -1.84% | $109.94 | 140K | Mar 1, 2024 | HCM APO Series LLC, Series C | F7, F8 |
| transaction | APO | Common Stock | Sale | -$2.56M | -23.2K | -16.55% | $110.41 | 117K | Mar 1, 2024 | HCM APO Series LLC, Series C | F8, F9 |
| transaction | APO | Common Stock | Sale | -$610K | -5.48K | -4.68% | $111.25 | 112K | Mar 1, 2024 | HCM APO Series LLC, Series C | F8, F10 |
| transaction | APO | Common Stock | Sale | -$101K | -900 | -0.81% | $112.67 | 111K | Mar 1, 2024 | HCM APO Series LLC, Series C | F8, F11 |
| holding | APO | Common Stock | 324K | Mar 1, 2024 | HCM APO Series LLC, Series A | F12 | |||||
| holding | APO | Common Stock | 27.4K | Mar 1, 2024 | HCM APO Series LLC, Series B | F13 | |||||
| holding | APO | Common Stock | 1.81M | Mar 1, 2024 | KRT Delaware LLC | F14 | |||||
| holding | APO | Common Stock | 9.39K | Mar 1, 2024 | KRT Investments LLC | F15 | |||||
| holding | APO | Common Stock | 4.58K | Mar 1, 2024 | KRT Investments VII LLC | F16 | |||||
| holding | APO | Common Stock | 440K | Mar 1, 2024 | KRT Investments IX LLC | F17 | |||||
| holding | APO | Common Stock | 702K | Mar 1, 2024 | The Kleinman Children's Trust | F18 | |||||
| holding | APO | Common Stock | 77.3K | Mar 1, 2024 | The Kleinman Descendant's GST-Exempt Trust | F19 | |||||
| holding | APO | Common Stock | 28.9K | Mar 1, 2024 | Heathcote Capital Partners LP | F20 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.88 to $109.99 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4), (5), (6), (7), (9), (10), and (11). |
| F2 | Reported amount includes 4,651,303 vested and unvested restricted stock units ("RSUs") granted under the Apollo Global Management, Inc. 2019 Omnibus Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive, in accordance with the issuance schedule set forth in the applicable RSU award agreement, one share of common stock of the Issuer for each vested RSU. The RSUs vest in installments in accordance with the terms of the applicable RSU award agreement, provided the reporting person remains in service through the applicable vesting date. |
| F3 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.99 inclusive. |
| F4 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.99 inclusive. |
| F5 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 to $112.86 inclusive. |
| F6 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.62 inclusive. |
| F7 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.88 to $109.995 inclusive. |
| F8 | Held by HCM APO Series LLC, Series C, a vehicle directly and indirectly wholly owned by the reporting person over which the reporting person exercises voting and investment control. |
| F9 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.98 inclusive. |
| F10 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.98 inclusive. |
| F11 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.10 to $113.045 inclusive. |
| F12 | Held by HCM APO Series LLC, Series A, a vehicle directly and indirectly wholly owned by the reporting person over which the reporting person exercises voting and investment control. |
| F13 | Held by HCM APO Series LLC, Series B, a vehicle directly and indirectly wholly owned by the reporting person over which the reporting person exercises voting and investment control. |
| F14 | Held by KRT Delaware LLC. The reporting person disclaims beneficial ownership of the securities indirectly or directly held by KRT Delaware LLC reported herein and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| F15 | Held by KRT Investments LLC. The reporting person disclaims beneficial ownership of the securities indirectly or directly held by KRT Investments LLC reported herein and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| F16 | Held by KRT Investments VII LLC, a vehicle directly and indirectly wholly owned by the reporting person over which the reporting person exercises voting and investment control. |
| F17 | Held by KRT Investments IX LLC ("Investments IX"). Investments IX is owned by the reporting person and a trust for the benefit of the reporting person's descendants and for which the reporting person's father acts as trustee. The reporting person disclaims beneficial ownership of the securities held by Investments IX, except to the extent of his direct or indirect pecuniary interest. |
| F18 | Held by The Kleinman Children's Trust, a vehicle directly and indirectly wholly owned by the reporting person over which the reporting person exercises voting and investment control. |
| F19 | Held by The Kleinman Descendant's GST-Exempt Trust, a vehicle directly and indirectly wholly owned by the reporting person over which the reporting person exercises voting and investment control. |
| F20 | Held by Heathcote Capital Partners LP, a vehicle directly and indirectly owned by the reporting person, his spouse and certain family trusts and over which the reporting person exercises voting and investment control. |
Co-President of Apollo Asset Management, Inc.